483
Granules Pharmaceuticals Inc.Granules Pharmaceuticals Inc. – FDA 483, Dec 15, 2023
Record Details
Granules Pharmaceuticals Inc. in Chantilly, VA, was inspected and cited for significant deficiencies in quality control, facility maintenance, equipment qualification, and material segregation. The firm failed to properly manage rejected materials, released drug products without adequate sampling, and operated unqualified equipment, indicating a lack of adherence to good manufacturing practices. These issues pose a risk to the identity, strength, quality, and purity of drug products.
View Company Profile
ID · ac2d6df3-5fe0-4df5-8fc5-fcd3805e2087
Other documents for Granules Pharmaceuticals Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.